大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/25 | 4,235 | 4,257 | 4,220 | 4,226 | +6 | +0.1% | 886,100 |
| 2023/01/24 | 4,189 | 4,237 | 4,175 | 4,220 | +55 | +1.3% | 1,038,900 |
| 2023/01/23 | 4,184 | 4,192 | 4,154 | 4,165 | +7 | +0.2% | 810,600 |
| 2023/01/20 | 4,155 | 4,158 | 4,128 | 4,158 | +28 | +0.7% | 957,700 |
| 2023/01/19 | 4,133 | 4,153 | 4,115 | 4,130 | -44 | -1.1% | 821,500 |
| 2023/01/18 | 4,088 | 4,177 | 4,060 | 4,174 | +96 | +2.4% | 1,389,600 |
| 2023/01/17 | 4,063 | 4,082 | 4,034 | 4,078 | +30 | +0.7% | 906,400 |
| 2023/01/16 | 4,015 | 4,064 | 4,011 | 4,048 | -9 | -0.2% | 757,900 |
| 2023/01/13 | 4,050 | 4,073 | 4,023 | 4,057 | -29 | -0.7% | 1,315,100 |
| 2023/01/12 | 4,091 | 4,104 | 4,068 | 4,086 | -1 | ±0% | 801,300 |
| 2023/01/11 | 4,057 | 4,103 | 4,056 | 4,087 | +45 | +1.1% | 1,024,200 |
| 2023/01/10 | 4,084 | 4,101 | 4,034 | 4,042 | -61 | -1.5% | 1,165,400 |
| 2023/01/06 | 4,099 | 4,128 | 4,089 | 4,103 | +3 | +0.1% | 783,000 |
| 2023/01/05 | 4,144 | 4,153 | 4,090 | 4,100 | -29 | -0.7% | 902,900 |
| 2023/01/04 | 4,251 | 4,257 | 4,129 | 4,129 | -176 | -4.1% | 970,200 |
| 2022/12/30 | 4,322 | 4,347 | 4,299 | 4,305 | -28 | -0.6% | 736,200 |
| 2022/12/29 | 4,354 | 4,359 | 4,292 | 4,333 | -71 | -1.6% | 792,000 |
| 2022/12/28 | 4,400 | 4,417 | 4,371 | 4,404 | +3 | +0.1% | 967,600 |
| 2022/12/27 | 4,421 | 4,435 | 4,401 | 4,401 | -7 | -0.2% | 562,900 |
| 2022/12/26 | 4,420 | 4,439 | 4,406 | 4,408 | -4 | -0.1% | 452,400 |
| 2022/12/23 | 4,421 | 4,445 | 4,387 | 4,412 | -31 | -0.7% | 905,100 |
| 2022/12/22 | 4,424 | 4,458 | 4,394 | 4,443 | +32 | +0.7% | 665,800 |
| 2022/12/21 | 4,427 | 4,446 | 4,398 | 4,411 | -39 | -0.9% | 834,800 |
| 2022/12/20 | 4,512 | 4,538 | 4,366 | 4,450 | -51 | -1.1% | 935,200 |
| 2022/12/19 | 4,504 | 4,523 | 4,484 | 4,501 | -32 | -0.7% | 786,000 |
| 2022/12/16 | 4,557 | 4,557 | 4,518 | 4,533 | -57 | -1.2% | 1,466,000 |
| 2022/12/15 | 4,602 | 4,645 | 4,589 | 4,590 | -22 | -0.5% | 593,000 |
| 2022/12/14 | 4,600 | 4,636 | 4,592 | 4,612 | +5 | +0.1% | 714,600 |
| 2022/12/13 | 4,595 | 4,627 | 4,583 | 4,607 | +46 | +1% | 844,000 |
| 2022/12/12 | 4,528 | 4,571 | 4,515 | 4,561 | -15 | -0.3% | 779,300 |
| 2022/12/09 | 4,512 | 4,601 | 4,512 | 4,576 | +49 | +1.1% | 1,279,100 |
| 2022/12/08 | 4,560 | 4,570 | 4,496 | 4,527 | -8 | -0.2% | 770,800 |
| 2022/12/07 | 4,497 | 4,552 | 4,476 | 4,535 | +13 | +0.3% | 777,600 |
| 2022/12/06 | 4,507 | 4,533 | 4,490 | 4,522 | +25 | +0.6% | 813,300 |
| 2022/12/05 | 4,548 | 4,551 | 4,467 | 4,497 | -34 | -0.8% | 1,186,400 |
| 2022/12/02 | 4,631 | 4,632 | 4,518 | 4,531 | -134 | -2.9% | 1,625,200 |
| 2022/12/01 | 4,726 | 4,740 | 4,654 | 4,665 | -25 | -0.5% | 978,400 |
| 2022/11/30 | 4,678 | 4,715 | 4,665 | 4,690 | +21 | +0.4% | 3,452,600 |
| 2022/11/29 | 4,695 | 4,704 | 4,657 | 4,669 | -45 | -1% | 797,300 |
| 2022/11/28 | 4,724 | 4,745 | 4,688 | 4,714 | -10 | -0.2% | 553,400 |
| 2022/11/25 | 4,762 | 4,778 | 4,716 | 4,724 | -35 | -0.7% | 754,000 |
| 2022/11/24 | 4,754 | 4,799 | 4,739 | 4,759 | +31 | +0.7% | 1,107,700 |
| 2022/11/22 | 4,677 | 4,764 | 4,677 | 4,728 | +76 | +1.6% | 822,200 |
| 2022/11/21 | 4,622 | 4,665 | 4,620 | 4,652 | +53 | +1.2% | 1,066,600 |
| 2022/11/18 | 4,553 | 4,600 | 4,546 | 4,599 | +71 | +1.6% | 631,800 |
| 2022/11/17 | 4,519 | 4,552 | 4,503 | 4,528 | +23 | +0.5% | 573,400 |
| 2022/11/16 | 4,532 | 4,541 | 4,495 | 4,505 | -37 | -0.8% | 740,600 |
| 2022/11/15 | 4,550 | 4,573 | 4,533 | 4,542 | +28 | +0.6% | 599,600 |
| 2022/11/14 | 4,556 | 4,591 | 4,509 | 4,514 | -68 | -1.5% | 928,100 |
| 2022/11/11 | 4,642 | 4,643 | 4,568 | 4,582 | +20 | +0.4% | 1,329,000 |
451～
500
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
